// App-Quantinova.ai

TCT-167 : Primary Endpoint Results of the TAXUS Liberte Post-Approval Study

Researchers

Presenter

  • David P. Lee

Principal Investigators

  • Richard Paulus

  • Kartik Giri

  • Jeffrey Carr

  • Kenneth W. Baran

  • David Hassel

  • Kenneth J. Winters

  • Thomas Christen

  • Keith D. Dawkins

  • Kirk N. Garratt

Medical Centers

  • Baptist Medical Center, Jacksonville, FL

  • Lenox Hill Hospital, New York, NY

  • King's Daughters Medical Center - Kentucky Heart Institute, Ashland, KY

  • Our Lady of Lourdes Medical Center, Camden, NJ

  • United Heart & Vascular Clinic, St Paul, MN

  • Tyler Cardiac and Endovascular Center, Tyler, TX

Locations

  • United States

Companies

  • Boston Scientific

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

  • Aspirin

  • Albyl-E

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved